Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Trends and challenges in immuno-oncology trials

B Kiernan1

  • 1Thomson Reuters, Portland, Maryland, USA. scientific.prousjournals@thomsonreuters.com.

Drugs of Today (Barcelona, Spain : 1998)
|August 20, 2016
PubMed

Insights

Immuno-oncology (I/O) harnesses the immune system to fight cancer, offering a new approach to precision medicine for treatment-resistant tumors. This immunotherapy strategy targets cancer pathways by utilizing the body's natural defense mechanisms.

Area of Science:

  • Oncology
  • Immunology
  • Precision Medicine

Background:

  • Immuno-oncology (I/O) represents a paradigm shift in cancer treatment.
  • Precision medicine is increasingly focusing on targeted therapies for specific patient subsets.
  • Conventional therapies often struggle with tumors resistant to treatment.

Purpose of the Study:

  • To highlight the transformative potential of immuno-oncology in cancer therapy.
  • To emphasize the shift towards targeted treatment strategies.
  • To introduce immunotherapy as a method to leverage the immune system against cancer.

Main Methods:

  • Focus on harnessing the patient's own immune system mechanisms.
  • Application of targeted therapies to specific tumor types.
  • Exploration of cancer pathways amenable to immune system intervention.

Main Results:

  • Immuno-oncology is redefining cancer treatment approaches.
  • Targeted therapies are being developed for previously resistant cancers.
  • Immunotherapy offers a novel strategy for cancer treatment.

Conclusions:

  • Immuno-oncology is a rapidly advancing field with significant therapeutic promise.
  • The integration of immunotherapy into precision medicine is crucial.
  • Harnessing the immune system presents a powerful avenue for combating cancer.
Keywords:
Cancer vaccinesCheckpoint inhibitorsImmuno-oncology

More Related Videos

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.2K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K